Muraki, Masato http://orcid.org/0000-0002-3406-5393
Kunita, Yuki
Shirahase, Ken
Yamazaki, Ryo
Hanada, Soichiro
Sawaguchi, Hirochiyo
Tohda, Yuji
Article History
Received: 8 September 2020
Accepted: 5 January 2021
First Online: 13 January 2021
Ethics approval and consent participate
: The study protocol (IRB #398, Jan. 2017) was approved by the Institutional Review Board at Kindai University Nara Hospital, and written informed consent was acquired from all subjects prior to enrollment into the study.
: Not applicable.
: Yuji Tohda received research grant from Kyorin pharmaceutical, MeijiSeika pharma, Boellringer Ingelheim, Teijin pharma, DaiichiSankyo, Astellas, and Pearl Therapeutics Inc. and received lecture fees from Kyorin pharmaceutical and Teijin Pharma, outside of the submitted work. Other authors have no competing interests to declare.